At close: December 23 at 5:32:15 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 2 | 21 | 20 |
| Avg. Estimate | 1.67B | 1.75B | 6.61B | 7.13B |
| Low Estimate | 1.63B | 1.69B | 6.55B | 6.82B |
| High Estimate | 1.73B | 1.81B | 6.8B | 7.43B |
| Year Ago Sales | 1.52B | 1.58B | 5.97B | 6.61B |
| Sales Growth (year/est) | 9.67% | 10.49% | 10.76% | 7.89% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RACE.VI | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 11/6/2024 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 10/22/2024 |
| Upgrade | JP Morgan: Neutral to Overweight | 10/11/2024 |
| Maintains | Morgan Stanley: Overweight to Overweight | 8/27/2024 |
| Upgrade | Barclays: Equal-Weight to Overweight | 8/2/2024 |
| Maintains | UBS: Buy to Buy | 6/24/2024 |